XNAS: GALT
Galectin Therapeutics Inc Live Stock Price Today, Share Analysis and Chart
about
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (G...
Read More
3.96
0.07
(1.80%)
258.4K
XNAS Volume
XNAS 21 Sep, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Moderately Bullish
Galectin Therapeutics Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..